In previous reports, we described founder variants in RSPH9 in eleven individuals shared by several unrelated Arabic families in our Kuwaiti PCD cohort (Al-Mutairi et al., 2023); we also reported novel founder variants in DNAI2 in seven individuals (Al-Mutairi et al., 2022). This evidence concerns the gene RSPH9 and primary ciliary dyskinesia.